Commercialization Readiness from Preclinical to 1st Launch: The First Time CEOs Playbook will equip early-stage biotechnology leaders with the commercialization knowledge they need to strategically position their organizations for financing success and meet critical Commercial and Medical Affairs milestones. The drug development process is complex and multifaceted, and understanding the commercialization considerations at each phase is vital. From preclinical to first product launch, this one-day course will help biotech executives make informed strategic choices for long-term success. Beginning with Phase I, this interactive course will cover the phase-specific commercialization activities and preparation emerging companies need to make for a successful first launch, including Market analysis with competitive landscape assessment, the Commercialization Roadmap development including launch critical success factors, FTEs and dollar spend required for launch, market access pricing and reimbursement, value proposition development, and go-to-market preparation and regulatory considerations. Note that these early commercial flows inform emerging biotech companies' corporate and partnering strategies. Russ Belden, founder and CEO of Bridge, will guide you through this course by sharing real-world examples and valuable insights. Russ is a biotech commercialization leader with over 36 years of senior operational experience in the preclinical to 1st launch space and a popular Biotech Primer instructor. About Biotech Primer:Biotech Primer is a trusted leader in delivering life sciences training that simplifies complex topics for non-scientists. With over 20 years of experience, industry-specific courses are expertly crafted to provide a clear understanding of the science, business, and regulatory frameworks essential for success in Biotechnology, Pharmaceuticals, Molecular Diagnostics, and Medical Devices. All BIO members receive a 15% discount on all…

Are you an executive or business development professional looking to take your negotiation skills to the next level? The Master the Art of Business Development Negotiations course is your gateway to achieving superior outcomes in complex negotiations.Negotiations are deeply intertwined with decision-making and the ability to influence others effectively. The better your (company's internal) decision-making and your (personal) influencing strategies, the more successful your negotiations will be. This course is uniquely designed to empower you with cutting-edge negotiation, decision-making, and influencing strategies. The course uses the powerful principles of game theory as one of its cornerstones. Many professionals already unknowingly use elements of game theory in their negotiations. Imagine what you will achieve by deliberately leveraging game theory, giving you an edge in anticipating your counterpart's moves, evaluating strategic options, and crafting winning strategies.A Hands-On, Interactive Experience:This in-person, highly interactive course is based on best practices and game theory and focuses on actionable insights. You’ll engage in real-life negotiation cases by diving into pharmaceutical and biotech case studies, including interactive group negotiations. Join us to transform the way you negotiate, influence, and decide. Gain the skills and confidence to drive exceptional results in every business negotiation. Sign up now and step into the future of strategic negotiation!NOTE: This course has a capped number of participants; people are encouraged to register early to reserve a spot.This one-day course will be held in-person on Sunday, June 15, 2025, in Boston. To add this course to your Convention registration, click the Register button.Interested in only registering for an in-person course in Boston? If you do not plan to attend the Convention but would like to register for a course only, please see the registration…

The "Product & Company Valuation" course is designed to teach a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals, or strategic development decisions in the pharma-biotech world. This introductory course is very valuable for pharma and biotech executives who are not familiar with compound and company valuations but need a thorough understanding of the valuation concepts and techniques that are commonly applied in the pharma and biotech industries. It goes beyond the number-crunching techniques of most consultants and includes difficult to define qualitative factors, which shape the risk profile of the company in question. This course optimally balances interactive lectures with practical group work exercises that are designed to help you practice the fundamental valuation tools & techniques taught throughout the day.Valuation is an inherently subjective task, which is made even more difficult in the life science industry due to its unique challenges: high attrition rates in R&D, long investment cycle, complex technologies, IP situations, etc. Therefore, traditional valuation methods are not suitable. Of particular value in this course is the “Product Valuation and Deal Structuring” module where registrants will learn the commonly used rNPV (i.e., risk-adjusted Net Present Value) method for calculating the value of a drug in development. Subsequently, you will practice how to structure a licensing deal between companies. Registrants will use an Excel-based tool designed specifically for this module, which can be taken home for future use.Topics covered in the Product & Company Valuation course include:Introduction to valuationAssessing a company prior to valuationCompany valuation and methodsProduct valuation and methodsDeal structuringThis one-day course will be held in person on June 15, 2025, in Boston. To add this course to your Convention…

The Guide to Raising Institutional Private Capital is a comprehensive course designed to teach biotech CEOs and CFOs of companies that have already raised a Series A and are preparing for a Series B or later on the most effective strategies for approaching institutional investors. The goal is to maximize the chances of successfully completing a significant private financing round.  Leveraging Locust Walk’s proven experience, participants will learn how to effectively position the company’s story, strategy, and value proposition for institutional investors. The course covers essential topics, including accurately calculating financing needs and use of proceeds, identifying appropriate institutional investors to target as a lead or syndicate member, understanding valuation methodologies for financings, dissecting the various components of a financing term sheet and their interactions, and cap table modeling.Topics covered in the Guide to Raising Institutional Private Capital course include:Portfolio & Financing Strategy and Company PositioningUse of Proceeds and BudgetingInvestor Identification and Syndicate CompositionMaterials CreationValuation Methodologies for FinancingsFinancing Term Sheet ReviewVenture Financing Math and ModelingThis one-day course will be held in person on Sunday, June 15, 2025, in Boston. To add this course to your Convention registration, click the Register button.Interested in only registering for an in-person course in Boston? If you do not plan to attend the Convention but would like to register for a course only, please see the registration instructions and use the registration code provided below. COURSE-ONLY REGISTRATION INSTRUCTIONSGo to our REGISTRATION WEBSITEStart New RegistrationEnter your Email, First Name, Last Name, and Company. Select “Continue”Provide requested personal information.Enter the code STAND25 in the first “Registration Code” box and select “Apply Code.”Select …

The Become a Biotech or MedTech Entrepreneur course covers everything from starting a company to specific market tactics. Suitable for scientists transitioning to industry, early-stage companies seeking partners or investment, and individuals with product ideas. Learn from experienced entrepreneurs and industry experts, gain critical resources, and save time with a comprehensive course.Who should take this course?Scientists and investigators who want to transition into industry.An early-stage company with technology and resources looking for additional investment or partners.People who have an idea for a product and want to know what steps they need to take to bring it to life in the marketplace.University technology transfer looking for entrepreneurs to take their spinouts.Each year, faculty from the event’s host region bring fresh insights to the program, while a core faculty returns to present material that has proven effective throughout the years. This two-day course will be held in-person, June 14--15, 2025, in Boston, Mass. To add this course to your Convention registration, click the Register button.Interested in only registering for an in-person course in Boston? If you do not plan to attend the Convention but would like to register for a course only, please see the registration instructions and use the registration code provided below. COURSE-ONLY REGISTRATION INSTRUCTIONSGo to our REGISTRATION WEBSITEStart New RegistrationEnter your Email, First Name, Last Name, and Company. Select “Continue”Provide requested personal information.Enter the code STAND25 in the first “Registration Code” box and select “Apply Code.”Select “Next”Complete the required fields. Review your information on the “Review and Check Out” page and select “Next” for payment options and to complete the registration.An e-mail confirmation will be sent automatically from the registration system. Please check your email filters if you do not…